Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2013 (2013), Article ID 504695, 4 pages
http://dx.doi.org/10.1155/2013/504695
Case Report

A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome

1Emory University, Department of Human Genetics, 2165 N. Decatur Road, Decatur, GA 30033, USA
2Florida State University College of Medicine, Tallahassee, FL 32304, USA

Received 24 May 2013; Accepted 4 August 2013

Academic Editors: S. Ennis and P. Saccucci

Copyright © 2013 Tovi Anderson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Dunn, “Dr Langdon Down (1828–1896) and 'mongolism',” Archives of Disease in Childhood, vol. 66, no. 7, pp. 827–828, 1991. View at Google Scholar · View at Scopus
  2. D. B. Bailey Jr., D. Skinner, and K. L. Sparkman, “Discovering fragile X syndrome: family experiences and perceptions,” Pediatrics, vol. 111, no. 2, pp. 407–416, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Hagerman, A. E. Chudley, and J. H. Knoll, “Autism in fragile X females,” American Journal of Medical Genetics, vol. 23, no. 1-2, pp. 375–380, 1986. View at Google Scholar · View at Scopus
  4. R. N. Hernandez, R. L. Feinberg, R. Vaurio, N. M. Passanante, R. E. Thompson, and W. E. Kaufmann, “Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation,” American Journal of Medical Genetics A, vol. 149, no. 6, pp. 1125–1137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Tsiouris and W. T. Brown, “Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy,” CNS Drugs, vol. 18, no. 11, pp. 687–703, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Stevens, N. Tartaglia, R. Hagerman, and K. Riley, “Clinical report: a male with down syndrome, fragile X syndrome, and autism,” Journal of Developmental and Behavioral Pediatrics, vol. 31, no. 4, pp. 333–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Collacott, D. P. Duckett, D. Mathews, J. S. Warrington, and I. D. Young, “Down's syndrome and fragile-X syndrome in a single patient,” Journal of mental deficiency research, vol. 34, no. part 1, pp. 81–86, 1990. View at Google Scholar · View at Scopus
  8. T. Arinami, I. Kondo, H. Hamaguchi, K. Tamura, and T. Hirano, “A fragile X female with down syndrome,” Human Genetics, vol. 77, no. 1, pp. 92–94, 1987. View at Google Scholar · View at Scopus
  9. S. S. Sparrow, D. V. Cicchetti, and D. A. Balla, Vineland Adaptive Behavior Scales, Survey Interview Form/Caretaker Rating Form, MN: Pearson Assessments, Livonia, MN, 2nd edition, 2005.
  10. T. M. Achenbach, Manual For the Child Behavior Checklist/4-18 and 1991 Profile, University of Vermont, Department of Psychiatry, Burlington, Mass, USA, 1991.
  11. J. Visootsak, S. T. Warren, A. Anido, and J. M. Graham Jr., “Fragile X syndrome: an update and review for the primary pediatrician,” Clinical Pediatrics, vol. 44, no. 5, pp. 371–381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. D'Hulst, N. De Geest, S. P. Reeve et al., “Decreased expression of the GABAA receptor in fragile X syndrome,” Brain Research, vol. 1121, no. 1, pp. 238–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. El Idrissi, X.-H. Ding, J. Scalia, E. Trenkner, W. T. Brown, and C. Dobkin, “Decreased GABAA receptor expression in the seizure-prone fragile X mouse,” Neuroscience Letters, vol. 377, no. 3, pp. 141–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. L. K. K. Pacey, S. P. Heximer, and D. R. Hampson, “Increased GABAB receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures,” Molecular Pharmacology, vol. 76, no. 1, pp. 18–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Berry-Kravis, A. Knox, and C. Hervey, “Targeted treatments for fragile X syndrome,” Journal of Neurodevelopmental Disorders, vol. 3, no. 3, pp. 193–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Leigh, D. V. Nguyen, Y. Mu et al., “A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile X syndrome,” Journal of Developmental & Behavioral Pediatrics, vol. 34, no. 3, pp. 147–155, 2013. View at Publisher · View at Google Scholar
  17. D. Z. Wetmore and C. C. Garner, “Emerging pharmacotherapies for neurodevelopmental disorders,” Journal of Developmental and Behavioral Pediatrics, vol. 31, no. 7, pp. 564–581, 2010. View at Publisher · View at Google Scholar · View at Scopus